Inflammatory response of lung macrophages and epithelial cells to tobacco smoke: A literature review of ex vivo investigations

Immunologic Research

Volumn 46, Issue 1-3, 2010, Pages 94-126

  Smith, Lauren A ^a   Paszkiewicz, Geraldine M ^a   Hutson, Alan D ^a   Pauly, John L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Chemokines; Cytokines; Inflammation; Lung; Macrophages; Tobacco smoke

Indexed keywords

CHEMOKINE; CYTOKINE; MATRIX METALLOPROTEINASE; PROTEINASE; REACTIVE OXYGEN METABOLITE; TOBACCO SMOKE;

ARTICLE; BIOASSAY; CIGARETTE SMOKING; CYTOKINE PRODUCTION; CYTOTOXICITY; EX VIVO STUDY; HUMAN; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; LUNG PARENCHYMA; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; TARGET CELL;

ANIMALS; EPITHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; MACROPHAGES, ALVEOLAR; SMOKE; TOBACCO;

EID: 77949423769     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-009-8133-6     Document Type: Article

References (103)

1. Nass SJ, Moses HL, editors. Cancer biomarkers-the promises and challenges of improving detection and treatment. Washington, DC:Institute of Medicine, The National Academies Press;2007. 252 p.
2. Engels EA. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther. 2008;8:605-15.
3. Tzortzaki EG, Manbiri I, Vlachaki E, Siafakas NM. Biomarkers in COPD. Curr Med Chem. 2007;14:1037-48.
4. Thacker EL. Lung inflammatory responses. Vet Res. 2006;37:469-86.
5. Nagata M. Inflammatory cells and oxygen radicals. Curr Drug Targets Inflamm Allergy. 2005;4:503-4.
6. Kulinsky VI. Biochemical aspects of inflammation. Biochemistry (Mosc). 2007;72:595-607.
7. Laberge S, El Bassam S. Cytokines, structural cells of the lungs and airway inflammation. Paediatr Respir Rev. 2004;5:S41-5.
8. Azad N, Rojanasakul Y, Yallyathan V. Inflammation and lung cancer: roles of reactive oxygen/ nitrogen species. J Toxicol Environ Health B Crit Rev. 2008;11:1-15.
9. Schwartz AG, Prysak GM, Bock CH, Cote ML. The molecular epidemiology of lung cancer. Carcinogenesis. 2007;28:507-18.
10. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-7.
11. Lawrence T. Inflammation and cancer: a failure of resolution. Trends Pharmacol Sci. 2007;28:162-5.
12. Higashimoto Y, Iwata T, Okada M, Satoh H, Fukuda K, Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Respir Med. 2009;103:1231-8.
13. Comandini A, Rogliani P, Nunziata A, Cazzola M, Curradi G, Saltini C. Biomarkers of lung damage associated with tobacco smoke in induced sputum. Respir Med. 2009;103:1592-613.
14. Collins CD, Purohit S, Podolsky RH, et al. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine. Vascul Pharmacol. 2006;45:258-67.
15. Bonassi S, Ugolini D, Kirsch-Volders M, Strömberg U, Vermeulen R, Tucker JD. Human population studies with cytogenetic biomarkers: review of the literature and future prospectives. Environ Mol Mutagen. 2005;45:258-70.
16. Maruvada P, Wang W, Wagner PD, Srivastava S. Biomarkers in molecular medicine: cancer detection and diagnosis. Biotechniques. 2005;38:S9-15.
17. Scaros O, Fisler R. Biomarker technology roundup: from discovery to clinical applications, a broad set of tools is required to translate from the lab to the clinic. Biotechniques. 2005;38:S30-2.
18. Enewold L, Mechanic LE, Bowman ED, et al. Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians. Cancer Epidemiol Biomarkers Prev. 2009;18:215-22.
19. van der Vaart H, Postma DS, Timens W, Ten Hacken NHT. Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax. 2004;59:713-21.
20. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007;131:1557-66.
21. D'hulst AI, Vermaelen KY, Brusselle GG, Joos GF, Pauwels RA. Time course of cigarette smokeinduced pulmonary inflammation in mice. Eur Respir J. 2005;26:204-13.
22. Kulkarni GS, Nadkarni PP, Cerreta JM, Ma S, Cantor JO. Short-term cigarette smoke exposure potentiates endotoxin-induced pulmonary inflammation. Exp Lung Res. 2007;33:1-13.
23. Spori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2:272-3.
24. Birrell MA, Wong S, Catley MC, Belvisi MG. Impact of tobacco-smoke on key signaling pathways in the innate immune response in lung macrophages. J Cell Physiol. 2008;214:27-37.
25. Doz E, Noulin N, Boichot E, et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol. 2008;180:1169-78.
26. Hecht SS. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg. 2006;391:603-13.
27. Pauly JL, Allison EA, Hurley EL, Nwogu CE, Wallace PK, Paszkiewicz GM. Fluorescent human lung macrophages analyzed by spectral confocal laser scanning microscopy and multispectral cytometry. Microsc Res Tech. 2005;67:79-89.
28. Streck RJ, Jezewski HM, Rodriquez MI, Hurley EL, Rich GA, Pauly JL. A method for isolating human lung macrophages and observations of autofluorescent phagocytes from the lungs of habitual cigarette smokers. J Immunol Methods. 1994;174:67-82.
29. Thiberville L, Salaün M, Lachkar S, et al. Human in vivo fluorescence microimaging of the alveolar ducts and sacs during bronchoscopy. Eur Respir J. 2009;33:974-85.
30. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol. 2006;72:1605-21.
31. Choi S, Myers JN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008;87:14-32.
32. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1-10.
33. Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G, Gorgoulis VG. Advances in the biology of oral cancer. Oral Oncol. 2007;43:523-34.
34. van Oijen MG, Gilsing MM, Rijksen G, Hordijk GJ, Slootweg PJ. Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol. 1998;34:297-303.
35. Taybos G. Oral changes associated with tobacco use. Am J Med Sci. 2003;326:179-82.
36. Oliver KG, Kettman JR, Fulton RJ. Multiplexed analysis of human cytokines by use of FlowMetrix system. Clin Chem. 1998;44:2057-60.
37. Hatsukami DK, Joseph AM, Lesage M, et al. Developing the science base for reducing tobacco harm. Nicotine Tob Res. 2007; Suppl 4:S537-53.
38. Parascandola M, Augustson E, O'Connell ME, Marcus S. Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands. Nicotine Tob Res. 2009;11:886-95.
39. Church TR, Anderson KE, Caporaso NE, et al. A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev. 2009;18:260-6.
40. Gaschler GJ, Zavitz CCJ, Bauer CMT, et al. Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages. Am J Respir Cell Mol Biol. 2008;38:216-26.
41. McMaster SK, Paul-Clark MJ, Walters M, Fleet M, et al. Cigarette smoke inhibits macrophage sensing of Gram-negative bacteria and lipopolysaccharide: relative roles of nicotine and oxidant stress. Br J Pharmacol. 2008;153:536-43.
42. Winkler AR, Nocka KH, Sulahian TH, Kobzik L, Williams CM. In vitro modeling of human alveolar macrophages smoke exposure: enhanced inflammation and impaired function. Exp Lung Res. 2008;34:599-629.
43. Facchinetti F, Amadei F, Geppetti P, et al. Alpha, beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am J Respir Cell Mol Biol. 2007;37:617-23.
44. Kang MJ, Homer RJ, Gallo A, et al. IL-18 is induced and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette smoke-induced pulmonary emphysema and inflammation. J Immunol. 2007;178:1948-59.
45. Lee KM, Renne RA, Harbo SJ, Clark ML, Johnson RE, Gideon KM. 3-Week inhalation exposure to cigarette smoke and/or lipopolysaccharide in AKR/J mice. Inhal Toxicol. 2007;19:23-35.
46. van der Deen M, Timens W, Timmer-Bosscha H, et al. Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice. Respir Res. 2007;8:49-56.
47. Yang S, Wright J, Bauter M, Seweryniak K, Kode A, Rahman I. Sirtuin regulates cigarette smokeinduced proinflammatory mediator release via RelA/p65 NK-κB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging. Am J Physiol Lung Cell Mol Physiol. 2007;292:L567-76.
48. Karimi K, Sarir H, Mortaz E, et al. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages. Respir Res. 2006;7:66-76.
49. Demirjian L, Abboud RT, Li H, Duronio V. Acute effect of cigarette smoke on TNF-α release by macrophages mediated through the erk1/2 pathway. Biochim Biophys Acta. 2006;1762:592-7.
50. Kubo S, Kobayashi M, Masunaga Y, et al. Cytokine and chemokine expression in cigarette smokeinduced lung injury in guinea pigs. Eur Respir J. 2005;26:993-1001.
51. Nordskog BK, Fields WR, Hellmann GM. Kinetic analysis of cytokine response to cigarette smoke condensate by human endothelial and monocytic cells. Toxicology. 2005;212:87-97.
52. Walters M, Paul-Clark M, McMaster S, Ito K, Adcock I, Mitchell J. Cigarette smoke activates human monocytes by an oxidant AP-1 signaling pathway: Implications for steroid resistance. Mol Pharmacol. 2005;68:1343-53.
53. Castro P, Legora-Machado A, Cardilo-Reis L, et al. Inhibition of interleukin-1β reduces mouse lung inflammation induced by exposure to cigarette smoke. Eur J Pharmacol. 2004;498:279-86.
54. Miller LM, Foster WM, Dambach DM, et al. A murine model of cigarette smoke-induce pulmonary inflammation using intranasally administered smoke-conditioned medium. Exp Lung Res. 2002;28:435-55.
55. Zhang X, Wang L, Zhang H, et al. The effects of cigarette smoke extract on the endothelial production of soluble intercellular adhesion molecule-1 are mediated through macrophages, possible by inducing TNF-α release. Methods Find Exp Clin Pharmacol. 2002;24:261-5.
56. Kyi M, Miyazaki Y, Inoue T, Miyake S, Matsukawa A, Yoshizawa Y. Acute effects of smoke exposure on the cellular and cytokine profile in isolated perfused lungs. Respir Physiol. 2000;123:143-51.
57. Edwards K, Braun KM, Evans G, Sureka AO, Fan S. Mainstream and sidestream cigarette smoke condensates suppress macrophage responsiveness to interferon c. Hum Exp Toxicol. 1999;18:233-40.
58. Hwang D, Chanmugam P, Boudreau M, Sohn KH, Stone K, Pryor WA. Activation and inactivation of cyclo-oxygenase in rat alveolar macrophages by aqueous cigarette tar extracts. Free Radic Biol Med. 1999;27:i673-82.
59. Braun KM, Cornish T, Valm A, Cundiff J, Pauly JL, Fan S. Immunotoxicology of cigarette smoke condensates: suppression of macrophage responsiveness to interferon γ. Toxicol Appl Pharmacol. 1998;149:136-43.
60. Dubar D, Gosset P, Aerts C, Voisin C, Wallaert B, Tonnel AB. In vitro effects of tobacco smoke on tumor necrosis factor α and interleukin-6 production by alveolar macrophages. Exp Lung Res. 1993;19:345-59.
61. Pessina GP, Paulesu L, Corradeschi F, et al. Production of tumor necrosis factor a by rat alveolar macrophages collected after acute cigarette smoking. Arch Immunol Ther Exp. 1993;41:343-8.
62. Higashimoto Y, Shimada Y, Fukuchi Y, et al. Inhibition of mouse alveolar macrophage production of tumor necrosis factor alpha by acute in vivo and in vitro exposure to tobacco smoke. Respiration. 1992;59:77-80.
63. Tardif J, Borgeat M, Laviolette M. Inhibition of human alveolar macrophage production of leukotriene B4 by acute in vitro and in vivo exposure to tobacco smoke. Am J Respir Cell Mol Biol. 1990;2:155-61.
64. Green GM. Mechanism of tobacco smoke toxicity on pulmonary macrophage cells. Eur J Respir Dis Suppl. 1985;139:82-5.
65. Voisin C, Aerts C, Fournier E, Firlik M. Acute effects of tobacco smoke on alveolar macrophages cultured in gas phase. Eur J Respir Dis. 1985;66:76-81.
66. Shea JW, Huber GL, Holmes L, Homans A. The effect of experimental tobacco smoke inhalation on in vitro alveolar macrophage bactericidal function. J Lab Clin Med. 1978;92:270-82.
67. Guarneri JJ. Influence of acute exposure to cigarette smoke on the alveolar macrophage system. J Lab Clin Med. 1977;89:1215-24.
68. Kent L, Smyth L, Clayton C, Scott L, et al. Cigarette smoke extract induced cytokine and chemokine gene expression changes in COPD macrophages. Cytokine. 2008;42:205-16.
69. Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-κB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. J Immunol. 2007;179:6097-106.
70. Koch A, Giembycz M, Stirling RG, et al. Effect of smoking on MAP kinase-induced modulation of IL-8 in human alveolar macrophages. Eur Respir J. 2004;23:805-12.
71. Grasseschi RM, Ramaswamy RB, Levine DJ, Klaassen CD, Wesselius LJ. Cadmium accumulation and detoxification by alveolar macrophages of cigarette smokers. Chest. 2003;124:1924-8.
72. Zeidel A, Beilin B, Yardeni I, Mayburd E, Smirnov G, Bessler H. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand. 2002;46:959-64.
73. Kotani N, Kushikata T, Hashimoto H, Sessler DI, Muraoka M, Matsuki A. Recovery of intraoperative microbicidal and inflammatory functions of alveolar immune cells after a tobacco smoke-free period. Anesthesiology. 2001;94:999-1006.
74. de Boer WI, Sount JK, van Schadewijk A, Stolk J, van Kreiken JH, Hiemstra PS. Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD. J Pathol. 2000;190:619-26.
75. Lim S, Roche N, Oliver BG, Mattos W, Barnes PJ, Chung KF. Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10. Am J Respir Crit Care Med. 2000;162:1355-60.
76. Mikuniya T, Nagai S, Tsutsumi T, et al. Proinflammatory or regulatory cytokines released from BALF macrophages of healthy smokers. Respiration. 1999;66:419-26.
77. Ohta T, Yamashita N, Maruyama M, Sugiyama E, Kobayashi M. Cigarette smoking decreases interleukin-8 secretion by human alveolar macrophages. Respir Med. 1998;92:922-7.
78. Staal-van den Brekel AJ, Dentener MA, Drent M, ten Velde GP, Buurman WA, Wouters EF. The enhanced inflammatory response in non-small cell lung carcinoma is not reflected in the alveolar compartment. Respir Med. 1998;92:76-83.
79. Dandrea T, Tu B, Blomberg A, et al. Differential inhibition of inflammatory cytokine release from cultured alveolar macrophages from smokers and non-smokers by NO2. Hum Exp Toxicol. 1997;16:577-88.
80. Wesselius LJ, Nelson ME, Bailey K, O'Brien-Ladner AR. Rapid lung cytokine accumulation and neutrophil recruitment after lipopolysaccharide inhalation by cigarette smokers and non-smokers. J Lab Clin Med. 1997;129:106-14.
81. Kuschner WG, D'Alesssandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J. 1996;9:1989-94.
82. Byron KA, Varigos GA, Wootton AM. IL-4 production is increased in cigarette smokers. Clin Exp Immunol. 1994;95:333-6.
83. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med. 1994;150:696-703.
84. Janson RW, King TE Jr, Hance KR, Arend WP. Enhanced production of IL-1 receptor antagonist by alveolar macrophages from patients with interstitial lung disease. Am Rev Respir Dis. 1993;148:495-503.
85. Yamaguchi E, Itoh A, Furuya K, Miyamoto H, Abe S, Kawakami Y. Release of tumor necrosis factor-alpha from human alveolar macrophages is decreased in smokers. Chest. 1993;103:479-83.
86. Soliman DM, Twigg HL III. Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am J Physiol. 1992;263:L471-8.
87. Nagai S, Aung H, Takeuchi M, Kusume K, Izumi T. IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases. Chest. 1991;99:674-80.
88. Brown GP, Iwamoto GK, Monick MM, Hunninghake GW. Cigarette smoking decreases interleukin 1 release by human alveolar macrophages. Am J Physiol. 1989;256:C260-4.
89. Renoux M, Lemarie E. Renoux G: Interleukin-1 secretion by lipopolysaccharide-stimulated alveolar macrophages. Respiration. 1989;55:158-68.
90. Yamaguchi E, Okazaki N, Itoh A, Abe S, Kawakami Y, Okuyama H. Interleukin 1 production by alveolar macrophages is decreased in smokers. Am Rev Respir Dis. 1989;140:397-402.
91. Petersen BH, Steimel LF, Callaghan JT. Suppression of mitogen-induced lymphocyte transformation in cigarette smoke. Clin Immunol Immunopathol. 1983;27:135-40.
92. Betsuyaku T, Hamamura I, Hata J, et al. Bronchiolar chemokine expression is different after single versus repeated cigarette smoke exposure. Respir Res. 2008;9:7-18.
93. Li W, Xu YJ, Shen HH. Effect of cigarette smoke extract on lipopolysaccharide-activated mitogen-activated protein kinase signal transduction pathway in cultured cells. Chin Med J (Engl). 2007;120:1075-81.
94. Glader P, Möller S, Lilja J, Wieslander E, Löfdahl CG, von Wachenfeldt K. Cigarette smoke extract modulates respiratory defence mechanisms through effects on T-cells and airway epithelial cells. Respir Med. 2006;100:818-27.
95. Kode A, Yang SR, Rahman I. Differential effects of cigarette smoke on oxidative stress and proin-flammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir Res. 2006;24:132-50.
96. Phillips J, Kluss B, Richter A, Massey ED. Exposure of bronchial epithelial cells to whole cigarette smoke: assessment of cellular responses. Altern Lab Anim. 2005;33:239-48.
97. Beisswenger C, Platz J, Siefart C, Vogelmeier C, Bals R. Exposure of differentiated airway epithelial cells to volatile smoke in vitro. Respiration. 2004;71:402-9.
98. Laan M, Bozinovski S, Anderson GP. Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J Immunol. 2004;173:4164-70.
99. Witherden IR, Vanden Bon EJ, Goldstraw P, Ratcliffe C, Pastorino U, Tetley TD. Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol. 2004;30:500-9.
100. Hellermann GR, Nagy SB, Kong S, Lockey RF, Mohapatra SS. Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Respir Res. 2002;3:22-9.
101. Richter A, O'Donnell RA, Powell RM, et al. Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke. Am J Respir Cell Mol Biol. 2002;27:85-90.
102. Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, Lozewicz S. Effect of cigarette smoke on the permeability and IL-1ß and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2000;23:530-6.
103. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennard SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med. 1997; 155:1770-6.